探讨混合作用 κ/μ 阿片受体双位点调节剂的变构调节的假定机制。
Exploring the putative mechanism of allosteric modulations by mixed-action kappa/mu opioid receptor bitopic modulators.
机构信息
Department of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University, Richmond, VA 23298, USA.
Center for Substance Abuse Research, Temple University Lewis Katz School of Medicine, Philadelphia, PA 19140, USA.
出版信息
Future Med Chem. 2021 Mar;13(6):551-573. doi: 10.4155/fmc-2020-0308. Epub 2021 Feb 16.
Abstract
The modulation and selectivity mechanisms of seven mixed-action kappa opioid receptor (KOR)/mu opioid receptor (MOR) bitopic modulators were explored. Molecular modeling results indicated that the 'message' moiety of seven bitopic modulators shared the same binding mode with the orthosteric site of the KOR and MOR, whereas the 'address' moiety bound with different subdomains of the allosteric site of the KOR and MOR. The 'address' moiety of seven bitopic modulators bound to different subdomains of the allosteric site of the KOR and MOR may exhibit distinguishable allosteric modulations to the binding affinity and/or efficacy of the 'message' moiety. Moreover, the 3-hydroxy group on the phenolic moiety of the seven bitopic modulators induced selectivity to the KOR over the MOR.
摘要
七种混合作用κ阿片受体（KOR）/μ阿片受体（MOR）双靶点调节剂的调节和选择性机制进行了研究。分子建模结果表明，七种双靶点调节剂的“信息”部分与 KOR 和 MOR 的正位点具有相同的结合模式，而“地址”部分与 KOR 和 MOR 的变构位点的不同亚域结合。七种双靶点调节剂的“地址”部分与 KOR 和 MOR 的变构位点的不同亚域结合，可能对“信息”部分的结合亲和力和/或效力表现出可区分的变构调节作用。此外，七种双靶点调节剂中酚部分上的 3-羟基基团诱导对 KOR 的选择性，而不是 MOR。
相似文献
1
Exploring the putative mechanism of allosteric modulations by mixed-action kappa/mu opioid receptor bitopic modulators.探讨混合作用 κ/μ 阿片受体双位点调节剂的变构调节的假定机制。
Future Med Chem. 2021 Mar;13(6):551-573. doi: 10.4155/fmc-2020-0308. Epub 2021 Feb 16.
2
Computational insights into the molecular mechanisms of differentiated allosteric modulation at the mu opioid receptor by structurally similar bitopic modulators.计算洞察结构相似的双位点调节剂在μ阿片受体上差异化变构调节的分子机制。
J Comput Aided Mol Des. 2020 Aug;34(8):879-895. doi: 10.1007/s10822-020-00309-x. Epub 2020 Mar 19.
3
Design, synthesis, and biological evaluation of 14-heteroaromatic-substituted naltrexone derivatives: pharmacological profile switch from mu opioid receptor selectivity to mu/kappa opioid receptor dual selectivity.14-杂芳基取代纳曲酮衍生物的设计、合成及生物评价：从μ阿片受体选择性到μ/κ阿片受体双重选择性的药理学特性转换。
J Med Chem. 2013 Nov 27;56(22):9156-69. doi: 10.1021/jm4012214. Epub 2013 Nov 7.
4
Controlling opioid receptor functional selectivity by targeting distinct subpockets of the orthosteric site.通过靶向变构结合位的不同亚口袋来控制阿片受体功能选择性。
Elife. 2021 Feb 8;10:e56519. doi: 10.7554/eLife.56519.
5
Binding mode characterization of 6α- and 6β-N-heterocyclic substituted naltrexamine derivatives via docking in opioid receptor crystal structures and site-directed mutagenesis studies: application of the 'message-address' concept in development of mu opioid receptor selective antagonists.通过在阿片受体晶体结构和定点突变研究中对接来研究 6α-和 6β-N-杂环取代的纳曲胺衍生物的结合模式：“信息-地址”概念在开发μ阿片受体选择性拮抗剂中的应用。
Bioorg Med Chem. 2013 Nov 1;21(21):6405-13. doi: 10.1016/j.bmc.2013.08.042. Epub 2013 Sep 4.
6
Analysis of [3H]bremazocine binding in single and combinatorial opioid receptor knockout mice.[3H]布瑞马佐辛在单基因和组合阿片受体敲除小鼠中的结合分析。
Eur J Pharmacol. 2001 Mar 2;414(2-3):189-95. doi: 10.1016/s0014-2999(01)00822-6.
7
Structural biology: How opioid drugs bind to receptors.结构生物学：阿片类药物如何与受体结合。
Nature. 2012 May 16;485(7398):314-7. doi: 10.1038/485314a.
8
Application of the message-address concept to the docking of naltrexone and selective naltrexone-derived opioid antagonists into opioid receptor models.信息-地址概念在纳曲酮及选择性纳曲酮衍生阿片类拮抗剂与阿片受体模型对接中的应用。
Neurochem Res. 1996 Nov;21(11):1287-94. doi: 10.1007/BF02532369.
9
Pharmacologic Evidence for a Putative Conserved Allosteric Site on Opioid Receptors.阿片受体假定变构位点的药理学证据。
Mol Pharmacol. 2018 Feb;93(2):157-167. doi: 10.1124/mol.117.109561. Epub 2017 Dec 12.
10
Spinal synthesis of estrogen and concomitant signaling by membrane estrogen receptors regulate spinal κ- and μ-opioid receptor heterodimerization and female-specific spinal morphine antinociception.脊髓合成的雌激素和膜雌激素受体的伴随信号调节脊髓 κ 和 μ 阿片受体异二聚体的形成和雌性特有的脊髓吗啡镇痛作用。
J Neurosci. 2011 Aug 17;31(33):11836-45. doi: 10.1523/JNEUROSCI.1901-11.2011.
引用本文的文献
1
Systematic Structure-Activity Relationship Study of Nalfurafine Analogues toward Development of Potentially Nonaddictive Pain Management Treatments.纳曲酮类似物用于开发潜在非成瘾性疼痛管理治疗的系统构效关系研究
J Med Chem. 2024 Jun 13;67(11):9552-9574. doi: 10.1021/acs.jmedchem.4c00646. Epub 2024 May 30.
2
NCP, a Dual Kappa and Mu Opioid Receptor Agonist, Is a Potent Analgesic Against Inflammatory Pain without Reinforcing or Aversive Properties.NCP是一种κ和μ阿片受体双重激动剂，是一种强效抗炎性疼痛镇痛药，无强化或厌恶特性。
J Pharmacol Exp Ther. 2024 Mar 15;389(1):106-117. doi: 10.1124/jpet.123.001870.
3
Biased, Bitopic, Opioid-Adrenergic Tethered Compounds May Improve Specificity, Lower Dosage and Enhance Agonist or Antagonist Function with Reduced Risk of Tolerance and Addiction.具有偏向性、双靶点、阿片-肾上腺素能连接的化合物可能会提高特异性、降低剂量，并增强激动剂或拮抗剂功能，同时降低耐受性和成瘾风险。
Pharmaceuticals (Basel). 2022 Feb 10;15(2):214. doi: 10.3390/ph15020214.
4
Structural Characterization of KOR Inactive and Active States for 3D Pharmacology and Drug Discovery.三维药理学和药物发现中 KOR 无活性和活性状态的结构特征。
Handb Exp Pharmacol. 2022;271:41-64. doi: 10.1007/164_2021_461.
本文引用的文献
1
Shedding light on the structural properties of lipid bilayers using molecular dynamics simulation: a review study.利用分子动力学模拟揭示脂质双层的结构特性：一项综述研究。
RSC Adv. 2019 Feb 6;9(8):4644-4658. doi: 10.1039/c8ra08441f. eCollection 2019 Jan 30.
2
Comparison of Pharmacological Properties between the Kappa Opioid Receptor Agonist Nalfurafine and 42B, Its 3-Dehydroxy Analogue: Disconnect between Agonist Bias and Pharmacological Effects.纳呋拉啡及其 3-去羟基类似物 42B 与κ阿片受体的药理学特性比较：激动偏向与药效学之间的脱节
ACS Chem Neurosci. 2020 Oct 7;11(19):3036-3050. doi: 10.1021/acschemneuro.0c00407. Epub 2020 Sep 24.
3
Modulation of cocaine-related behaviors by low doses of the potent KOR agonist nalfurafine in male C57BL6 mice.低剂量强效 κ 阿片受体激动剂纳呋拉啡对雄性 C57BL6 小鼠可卡因相关行为的调制。
Psychopharmacology (Berl). 2020 Aug;237(8):2405-2418. doi: 10.1007/s00213-020-05543-7. Epub 2020 May 20.
4
Computational insights into the molecular mechanisms of differentiated allosteric modulation at the mu opioid receptor by structurally similar bitopic modulators.计算洞察结构相似的双位点调节剂在μ阿片受体上差异化变构调节的分子机制。
J Comput Aided Mol Des. 2020 Aug;34(8):879-895. doi: 10.1007/s10822-020-00309-x. Epub 2020 Mar 19.
5
The atomistic level structure for the activated human κ-opioid receptor bound to the full Gi protein and the MP1104 agonist.激活的人 κ-阿片受体与完整 Gi 蛋白和 MP1104 激动剂结合的原子水平结构。
Proc Natl Acad Sci U S A. 2020 Mar 17;117(11):5836-5843. doi: 10.1073/pnas.1910006117. Epub 2020 Mar 3.
6
Recent Insights from Molecular Dynamics Simulations for G Protein-Coupled Receptor Drug Discovery.从分子动力学模拟看 G 蛋白偶联受体药物研发的新进展。
Int J Mol Sci. 2019 Aug 29;20(17):4237. doi: 10.3390/ijms20174237.
7
Clinically utilized kappa-opioid receptor agonist nalfurafine combined with low-dose naltrexone prevents alcohol relapse-like drinking in male and female mice.临床应用的κ-阿片受体激动剂纳呋拉啡联合小剂量纳曲酮可预防雄性和雌性小鼠的酒精复饮样饮酒。
Brain Res. 2019 Dec 1;1724:146410. doi: 10.1016/j.brainres.2019.146410. Epub 2019 Aug 27.
8
Brain and Cognition for Addiction Medicine: From Prevention to Recovery Neural Substrates for Treatment of Psychostimulant-Induced Cognitive Deficits.成瘾医学的脑与认知：从预防到康复 治疗精神兴奋剂所致认知缺陷的神经基质
Front Psychiatry. 2019 Jul 24;10:509. doi: 10.3389/fpsyt.2019.00509. eCollection 2019.
9
Kappa Opioid Receptor Agonist Mesyl Sal B Attenuates Behavioral Sensitization to Cocaine with Fewer Aversive Side-Effects than Salvinorin A in Rodents.κ 阿片受体激动剂甲磺酰基萨布素 B 比沙蒽酮 A 更能减轻可卡因引起的行为敏化，且不良反应更少。
Molecules. 2018 Oct 11;23(10):2602. doi: 10.3390/molecules23102602.
10
Molecular Dynamics Simulation for All.分子动力学模拟概览。
Neuron. 2018 Sep 19;99(6):1129-1143. doi: 10.1016/j.neuron.2018.08.011.
Zotero 插件